Psoriatic Arthritis (PsA) is as an inflammatory arthritis, usually seronegative (for rheumatoid factor), associated with psoriasis. It has been reported in 6-39% of patients with psoriasis 1, 2, 3, 4, 5 . The initial description of PsA by Wright suggested it was milder than rheumatoid arthritis (RA) 6 . Subsequent studies suggested patients with PsA fared better than patients with RA 7 . PsA was thus considered a benign disease, with short-lived synovitis that did not lead to residual damage in the majority of patients. This may be partly explained by our observation that PsA patients have a lower frequency of fibromyalgia, as well as a lower pain threshold in both actively inflamed joints and fibromyalgia tender points than RA patients, and thus both patients and physicians have underestimated the degree of inflammation 8 . However, in the past 15 years it has become clear that PsA may be more severe than previously thought. Recent studies have shown that 67% of the patients seen in a psoriatic arthritis clinic have at least one erosion documented at presentation to clinic 9, 10 . Indeed, of 129 patients identified as having psoriatic arthritis in an early arthritis clinic, 47% developed joint erosions by 2 years 11 . Moreover, some 20% of the patients registered in a longitudinal PsA Clinic demonstrated more than 5 deformed joints at presentation, and 11% had markedly reduced functional class 9 .
We have previously demonstrated that, after 10 years of follow up, 55% of the patients with PsA developed 5 or more damaged joints 12 . Others have also documented progression of deformity and radiological damage in PsA over time 13, 14 . The presence of 5 or more swollen joints at presentation to clinic, and a high level of medication prior to presentation were found in one study to be predictors of progression of clinical damage, while a low erythrocyte sedimentation rate was protective 15 . Polyarticular presentation predicted progression of both clinical and radiological damage in another study 14 . Indeed, actively inflamed joints at any visit were predictive of progression of clinical damage at subsequent visits, such that for each actively inflamed joint detected at one visit, there was a 4% increased risk of progression of damage in a subsequent visit 16 . In addition, the HLA antigens HLA-B27 in the presence of HLA-DR7, HLA-B39, and HLA-DQw3 in the absence of HLA-DR7 were identified as risk factors for progression of clinical damage, while HLA-B22 was protective 17 . In our previous studies we used clinical damage, determined by the presence of a limitation of range of movement of more than 20% of the range not related to the presence of joint effusion, the presence of joint deformities, subluxation, loosening or ankylosis, as the outcome measure, since it was measured at every visit. However, the assessment of radiological damage has been considered a more traditional method of assessing damage in patients with arthritis. The relationship between radiological damage (erosions, joint space narrowing, ankylosis and joint lysis) and clinical damage (deformities, limitation of movement, ankylosis and loosening of the joints) is unclear. Some patients appear to have evidence of clinical deformity without obvious changes on their radiographs, whereas others demonstrate erosive changes with joint space narrowing without obvious deformities. We therefore aimed to determine whether the detection of clinical damage preceded or followed radiological damage in our patients with PsA, and to identify disease related features that were associated with the development of clinical and radiological joint damage.
METHODS
The database used was based on the cohort of patients registered in the Psoriatic Arthritis Clinic at the University of Toronto. This clinic registry began accruing patients in 1978 and is now the largest registry of patients with PsA with detailed prospective follow-up. Upon entry to the University of Toronto PsA clinic, detailed demographic and historical data are recorded in a standardized form 9 .
group.bmj.com on April 19, 2017 -Published by http://ard.bmj.com/ Downloaded from For the present study we restricted eligibility to patients who were accrued between 1978 and 2003. There were 655 patients in this dataset. Patients are scheduled for semi-annual clinical assessment (which include a clinical history, physician examination and laboratory evaluation according to a standard protocol) and biannual radiographic assessment. Joints are classified upon clinical examination of damage as being normal, deformed, ankylosed, flail or having been surgically replaced. Joints which demonstrate reduced range of movement of more than 20% of the range but demonstrate an effusion, a balottable swelling suggesting that the fluid may be contributing to the limitation of movement, are not considered damaged as once the inflammation resolves the joint may restore its range of movement. This definition was based on a workshop in which the rheumatologists of the University of Toronto Rheumatic Disease Unit participated in 1978, at the initiation of the PsA Clinic. The assessment of clinically damage joints has been proven reliable both by physicians who trained at the University of Toronto PsA clinic 18 and by physicians from across Canada who participated in an exercise to assess patients with PsA 19 . Radiographic examination, based on a modified Steinbrocker scoring system 20 leads to a characterization in terms of the categories normal (with possible soft tissue swelling), surface or pocket erosions, erosion and joint space narrowing, disorganization (including total ankyslosis, pencil-in-cup change or total joint destruction) or as having required surgery. We define a joint as damaged clinically or radiologically if it is anything other than normal. In this analysis we consider only the joints in the hands (28 joints altogether, 14 in each hand, the MCPs, PIPs and DIPs including thumbs and fingers). The assessments of radiological damage have proven reliable in our clinic 20 . All data pertaining to these joints in all patients over the period of observation were examined in our analysis. The data were used to define, if possible, the method that first detected damage. This is primarily determined by clinic visits at which both clinical and radiological damage are assessed. Since clinical damage is assessed at all clinic visits while x-rays are taken biannually only visits in which both clinical and radiological damage were measured were considered in the analysis. When information on both radiological and clinical damage is available, then four scenarios are possible. If radiological damage is first seen at a visit when clinical damage is not seen then it is known that radiological damage was detected first. If radiological damage is not seen at a visit when x-rays are taken but clinical damage is observed, then it is known that clinical damage was detected first. If the first detection of both types of damage is at the same visit then detection is regarded as simultaneous. Finally, if radiological damage is detected at a visit but clinical damage has been seen at a previous visit when no x-rays were taken, then it is not possible to determine order since radiological damage could have been present earlier. In addition to these four scenarios concerning visits when both radiological and clinical damage are assessed, if clinical damage is detected but no concurrent or subsequent radiological assessment is done, then the order of detection cannot be determined.
Joints which were first classified as damaged by both methods are not informative, since it was not possible to determine which method had detected damage first. We therefore excluded such joints, and joints for which the order of detection could not be determined, from the analysis. Note that joints which were not classified as damaged by either method continued to be tracked over eligible follow-up visits. If at the end of the follow-up a joint was not classified as damaged by any method then this joint is excluded from the analysis, since it is not informative.
We were thus able to characterize each joint for each patient into one of the following categories:
A: never been detected as damaged by either method B: first detected as damaged by clinical assessment C: first detected as damaged by radiological assessment D: first detected as damaged by both clinical and radiological assessments or not able to determine. The percentage of joints in each category was computed. Outcomes A and D represent concordance and B and C represent discordance. To help identify patient characteristics which predict characterization of damage by radiographic assessment before clinical assessment, the discordant outcomes B and C are informative and the outcomes A and D lead to the joint being excluded from the analysis as uninformative. For each informative joint, a binary response was constructed which took the value 1 if a radiological assessment led to a classification of damage first (case C) and 0 if a clinical assessment led to the classification of damage first (case B).
Since joints from the same patient may tend to behave in a more similar fashion than joints from different patients, methods for dealing with cluster-correlated binary data are required. We therefore used generalized estimating equations 21 to fit logistic regression models to identify factors which predict classification of damage by radiographic assessment first. An exchangeable working correlation structure between the cross-sectional visit data was used. This working assumption appears sensible in light of the irregular spacing of clinic visits but the use of generalized estimating equation methodology provides an analysis that is robust to departures from this assumption.
In addition to the primary analysis of cross-sectional visit data, a descriptive longitudinal analysis of time to damage and the gap between damage detection by the different methods was done using Kaplan-Meier like methodology. Table 1 provides a summary of patient characteristics for the 655 patients included in this analysis. All patterns of damage observed 62 (9.5%)
RESULTS
The numbers of joints in categories A, B, C and D, as defined in the Methods, were 14298, 565, 2370 and 1107 respectively. Of the joints that became damaged, simultaneous detection by clinical and radiological means could not be ruled out for 27% (1107/4042). Of the remainder, 81% (2370/2935) were seen first on x-rays and 19% were first detected clinically.
Of the 2370 joints detected first radiologically, 1447 demonstrated surface erosions only, 716 demonstrated erosions and joint space narrowing and 207 were in other categories. For the 565 joints detected first clinically, 492 were deformed, 45 ankylosed and 28 in the other categories. Table 3 presents the results of univarate GEE logistic regression analyses of the relationships between the factors listed in the methods and the probability of having radiological damage detected first. The variable recent history of effusions is coded 1 if a joint was swollen on the two previous clinic visits, or on the previous visit if data from clinic visit 2 were being used. Observations from clinic visit 1 were excluded for any model involving this variable. The medication level was determined by the highest level of medication the patient was receiving at the time the joint under consideration was detected as damaged (the order is: No medication => NSAIDS => DMARDS => IAS).
Only four variables achieved significance levels below 0.05. These were arthritis duration at time of clinic entry (p=0.04), arthritis duration at time of damage detection (p=0.01), duration of psoriasis at time of damage detection (p=0.03), and recent history of effusions (p=0.002).
When the four variables identified in the univariate analyses were considered in a multivariate model, only arthritis duration at clinic entry (OR=0.97/year, p=0.01) and recent history of effusions (OR=1.72, p=0.002) retained significance. In addition, there was some evidence (p=0.04) of an interaction between swelling at the time of damage detection and recent history of effusions defined as swelling in the previous two clinic visits. The estimated odds ratios for recent effusion history from a model including this interaction were 1.39 with no current swelling and 3.34 with current swelling.
No qualitative changes in these results were observed when analysis was restricted to patients with arthritis duration at clinic visit less than two years or when restricted to patients with no damage at first clinic visit. There was also no evidence that the type of damage detected in a patient's joints at first visit influenced the pattern of subsequent damage development.
A descriptive analysis was also undertaken of the gap between radiological and clinical damage detection at the joint level. No adjustment for the correlation between joints in the same patient has been made as no significance tests are presented. The data for this analysis are necessarily restricted to joints that had no damage detected by either method on clinic entry since otherwise the relevant timings cannot be determined. Figure 1 presents two curves for the time to first damage in individual joints, detected radiologically and detected clinically. The time scale is the time since clinic entry in years. It can be seen that although radiologically detected damage does occur earlier, the curves track fairly closely together. These estimated curves take account of the interval censoring introduced by observations only being made at clinic visits for clinical damage and biannual clinic visits for radiological damage. Figure 2 presents data on the number of subsequent visits to a joint being detected by clinical or radiological assessment, given that it was detected first by the other method. Long gaps can occur and slightly greater delays occur for clinical following radiological detection compared with radiological following clinical detection.
DISCUSSION
The evaluation of patients with PsA includes assessment of joint inflammation, namely the number of tender and swollen joints, and the assessment of joint damage, comprising both clinical and radiological damage 22 . The clinical assessment of actively inflamed and damaged joints has been shown reliable in our own clinic, as well as among Canadian Rheumatologists 18, 19 . Clinical damage can be assessed at each clinical encounter with the patient, whereas radiological damage requires the patient to undergo a series of radiographs. The relationship between clinical and radiological damage, and the role of joint inflammation in the development of damage has not been addressed previously. We aimed to study clinical and radiological damage in patients with PsA followed in a longitudinal clinic, and to relate the means of detection of damage to disease related features. We found that in 81% of the informative joints, damage was first detected radiologically whereas in 19% of the joints damage was first detected clinically.
However, patients are often reluctant to undergo radiographic assessment because of fear of excessive radiation. Therefore, it is important to determine whether information can be gained from the assessment of clinical damage. Considering all categories of clinical and radiological damage, clinical damage was detected at the same time or before radiological damage in 41% of the time ((565 + 1107) /4042). It is possible that we have underestimated clinical damage in some patients as we do not assign damage to a joint that is clinically swollen. This was done on purpose since we have seen situations in which patients appeared to have a flexion contracture associated with joint swelling which disappeared once the joint was injected with corticosteroids and the inflammation resolved. We did not want to erroneously assign a joint to a damage state since the underlying assumption is that damage does not recover. If we underestimated the number of joints with damage, there might be an even greater correlation between the development of clinical and radiological damage.
This study demonstrates that, based on informative joints, radiographic detection occurred first in the majority of patients, and that the presence of effusions is associated with the development of radiological damage in these joints. It should be noted, however, that the detection of clinical damage followed closely. Since the evaluation of clinical damage can be performed at each patient encounter and does not require further effort on the part of the patient, it may be a worthwhile tool both in the management of patients with PsA in the clinic and as an outcome measure in clinical trials. 
